标题
Optimizing treatment success in multiple sclerosis
作者
关键词
Brain atrophy, Disability evaluation, Drug therapy, Multiple sclerosis
出版物
JOURNAL OF NEUROLOGY
Volume 263, Issue 6, Pages 1053-1065
出版商
Springer Nature
发表日期
2015-12-24
DOI
10.1007/s00415-015-7986-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
- (2015) Tjalf Ziemssen et al. BMC Neurology
- Treating relapsing–remitting multiple sclerosis: therapy effects on brain atrophy
- (2015) Angela Vidal-Jordana et al. JOURNAL OF NEUROLOGY
- Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study
- (2015) D. H. Miller et al. NEUROLOGY
- Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial
- (2015) L. Kappos et al. NEUROLOGY
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Optimizing therapy early in multiple sclerosis: An evidence-based view
- (2015) Tjalf Ziemssen et al. Multiple Sclerosis and Related Disorders
- Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
- (2014) Nicola De Stefano et al. CNS DRUGS
- Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
- (2014) Douglas L. Arnold et al. JOURNAL OF NEUROLOGY
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model
- (2014) Martin Stangel et al. Therapeutic Advances in Neurological Disorders
- Comparison of patient-reported outcome measures in multiple sclerosis
- (2013) N. Schäffler et al. ACTA NEUROLOGICA SCANDINAVICA
- Randomized study combining interferon and glatiramer acetate in multiple sclerosis
- (2013) Fred D. Lublin et al. ANNALS OF NEUROLOGY
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Disease-specific molecular events in cortical multiple sclerosis lesions
- (2013) Marie Therese Fischer et al. BRAIN
- Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients
- (2013) Tjalf Ziemssen et al. JOURNAL OF NEURAL TRANSMISSION
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy of subcutaneous interferon -1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
- (2013) N. De Stefano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Refining response to treatment as defined by the Modified Rio Score
- (2013) MP Sormani et al. Multiple Sclerosis Journal
- Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
- (2013) Angela Vidal-Jordana et al. Multiple Sclerosis Journal
- Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis
- (2013) Luca Prosperini et al. Multiple Sclerosis Journal
- The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients
- (2013) Özgür Yaldizli et al. Multiple Sclerosis Journal
- Defining and scoring response to IFN-β in multiple sclerosis
- (2013) Maria Pia Sormani et al. Nature Reviews Neurology
- Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis
- (2013) Robert Zivadinov et al. RADIOLOGY
- Magnetic resonance monitoring of lesion evolution in multiple sclerosis
- (2013) Àlex Rovira et al. Therapeutic Advances in Neurological Disorders
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
- (2012) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
- (2012) Giancarlo Comi et al. Multiple Sclerosis Journal
- Scoring treatment response in patients with relapsing multiple sclerosis
- (2012) MP Sormani et al. Multiple Sclerosis Journal
- Survival in MS
- (2012) D.S. Goodin et al. NEUROLOGY
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes
- (2011) R. Philip Kinkel ARCHIVES OF NEUROLOGY
- Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?
- (2011) Luca Prosperini et al. BMC Neurology
- Multiple sclerosis: current treatment algorithms
- (2011) Jordi Río et al. CURRENT OPINION IN NEUROLOGY
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
- (2011) E Kingwell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
- (2011) Douglas S Goodin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
- (2011) Bhupendra Khatri et al. LANCET NEUROLOGY
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
- (2011) Giancarlo Comi et al. LANCET NEUROLOGY
- MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
- (2011) Frederik Barkhof et al. Nature Reviews Neurology
- A critical appraisal of treatment decisions in multiple sclerosis—old versus new
- (2011) Bernd C. Kieseier et al. Nature Reviews Neurology
- Consenso español sobre la utilización de natalizumab (Tysabri®) - 2011
- (2011) O. Fernández et al. NEUROLOGIA
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy
- (2011) Tamara Castillo-Trivino et al. PLoS One
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
- (2010) Ernst-Wilhelm Radue et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
- (2010) N. De Stefano et al. NEUROLOGY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maximising therapeutic outcomes in patients failing on current therapy
- (2009) Christina Caon JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple sclerosis beyond EDSS: depression and fatigue
- (2009) Tjalf Ziemssen JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
- (2009) Ludwig Kappos et al. LANCET NEUROLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Social consequences of multiple sclerosis (1): early pension and temporary unemployment—a historical prospective cohort study
- (2009) Claudia Christina Hilt Pfleger et al. Multiple Sclerosis Journal
- Measures in the first year of therapy predict the response to interferon β in MS
- (2009) J Río et al. Multiple Sclerosis Journal
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina
- (2008) A. Carrá et al. EUROPEAN JOURNAL OF NEUROLOGY
- The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome
- (2008) Robert Zivadinov et al. JOURNAL OF NEUROLOGY
- Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
- (2008) et al. JOURNAL OF NEUROLOGY
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway
- (2008) N Grytten Torkildsen et al. Multiple Sclerosis Journal
- Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
- (2008) J Río et al. Multiple Sclerosis Journal
- Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosis
- (2008) A Gajofatto et al. Multiple Sclerosis Journal
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
- Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
- (2007) A Minneboo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cognitive impairment in different MS subtypes and clinically isolated syndromes
- (2007) Constantin Potagas et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search